Fifty years of obstetrics and gynaecology

Obstetrics and Gynaecology

Professor of obstetrics and gynaecology

randomised studies of the widely used immunosuppressive regimens for treating sperm antibodies, though a study is now under way. No controlled trials of different methods of in vitro fertilisation have used childbirth as the end point. Thus the first advance must be to organise randomised controlled trials to test widely used treatments. In order to avoid the type II error large cohort sizes wi...

Bromocriptine in obstetrics and gynaecology.

Bromocriptine, the active ingredient of Parlodel is a specific dopamine receptor agonist available for use in clinical practice. It has been successfully used in the treatment of hyperprolactinemia with associated amenorrhea, galactorrhea and infertility; in the inhibition of postpartum lactation; acromegaly and in Parkinson's disease. Its role in obstetrics and gynaecology is strategic since i...

Prostaglandins in obstetrics and gynaecology.

THE first reports of the use of the natural prostaglandins in the field of obstetrics and gynaecology appeared in 1968, initially for the induction of term labour in patients with fetal death and subsequently for patients with a live fetus. Since then numerous clinical reports have described the efficacy of using prostaglandins for this purpose administered by a variety of different routes and ...

21st European Congress of Obstetrics and Gynaecology.

The 21st European Congress of Obstetrics and Gynaecology took place in Antwerp 5-8 May 2010. The congress provided the participants with an overview of recent scientific and clinical developments throughout the field of obstetrics and gynaecology, and these are summarized in this article.